Prognostic role of sarcopenia in metastatic colorectal cancer patients during first-line chemotherapy: A retrospective study-Reference-Cited by-同舟云学术

Prognostic role of sarcopenia in metastatic colorectal cancer patients during first-line chemotherapy: A retrospective study

Published:2021-05-24 Issue:5 Volume:12 Page:355-366
ISSN:2218-4333
Container-title:World Journal of Clinical Oncology
language:
Short-container-title:WJCO

Author:

Maddalena Chiara,Ponsiglione Andrea,Camera Luigi,Santarpia Lidia,Pasanisi Fabrizio,Bruzzese Dario,Panico Camilla,Fiore Giovanni,Camardella Simona,Caramia Tolomeo,Farinaro Alessia,De Placido Sabino,Carlomagno Chiara

Publisher

Baishideng Publishing Group Inc.

Subject

Oncology

Reference50 articles.

1. Flat-Fixed Dosing Versus Body Surface Area–Based Dosing of Anticancer Drugs in Adults: Does It Make a Difference?

2. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 1989; 5: 303-11; discussion 312

3. Role of Body Surface Area in Dosing of Investigational Anticancer Agents in Adults, 1991-2001

4. Relationships between body composition parameters and fluorouracil pharmacokinetics

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sarcopenic Obesity and Outcomes for Patients With Cancer;JAMA Network Open;2024-06-14

2. Call for standardization in assessment and reporting of muscle and adipose change using computed tomography analysis in oncology: A scoping review;Journal of Cachexia, Sarcopenia and Muscle;2023-09-07

3. Radiological Assessment of Sarcopenia and Its Clinical Impact in Patients with Hepatobiliary, Pancreatic, and Gastrointestinal Diseases: A Comprehensive Review;Journal of Gastrointestinal and Abdominal Radiology;2023-08-04

4. Low skeletal muscle mass predicts treatment response in oncology: a meta-analysis;European Radiology;2023-03-16

5. Sarcopenia remaining after intensive nutritional feeding support could be a criterion for the selection of patients for surgery for oesogastric junction adenocarcinoma;European Journal of Surgical Oncology;2023-02